Physician

Golden Thaddeus Buckland, M.D.

According to 2025 Medicare claims, Golden Buckland, M.D. (NPI: 1942402904) practices ophthalmology in the Coeur d'Alene, ID market, with the plurality of this provider's patient population coming from Kootenai, ID. This provider's primary affiliated billing organization is NORTH IDAHO EYE INSTITUTE P A (NPI: 1699811646; TIN: 820448111) and primary practice location at 83814-2540. Buckland is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), participating under the MSSP model.

Buckland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 924 traditional Medicare patients, billed 17,607 HCPCS/CPT codes, and received $1,445,980 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,332 prescription claims across 391 beneficiaries totaling $238,493 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 8 records totaling $301. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$996K$2.0M2015 Medicare payment: $1,991,036 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,865,886 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,604,364 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,549,335 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,527,591 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,342,148 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,326,243 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,387,092 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,280,002 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,445,980 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0697,612$1,991,036
20161,1167,637$1,865,886
20171,2037,181$1,604,364
20181,1887,262$1,549,335
20191,2057,301$1,527,591
20201,0926,801$1,342,148
20211,0496,688$1,326,243
20229978,251$1,387,092
202397013,221$1,280,002
202492417,607$1,445,980

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$119K$238K2015 Drug cost: $140,612 (USD; Tot_Drug_Cst)2016 Drug cost: $164,249 (USD; Tot_Drug_Cst)2017 Drug cost: $179,696 (USD; Tot_Drug_Cst)2018 Drug cost: $234,714 (USD; Tot_Drug_Cst)2019 Drug cost: $222,783 (USD; Tot_Drug_Cst)2020 Drug cost: $201,208 (USD; Tot_Drug_Cst)2021 Drug cost: $168,397 (USD; Tot_Drug_Cst)2022 Drug cost: $166,594 (USD; Tot_Drug_Cst)2023 Drug cost: $233,323 (USD; Tot_Drug_Cst)2024 Drug cost: $238,493 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153891,498$140,612
20163891,545$164,249
20175642,144$179,696
20186012,426$234,714
20195242,075$222,783
20203621,431$201,208
20213271,177$168,397
20223361,158$166,594
20233701,181$233,323
20243911,332$238,493

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye181811$85
92014Established patient complete exam of visual system620698$77
92012Established patient problem focused exam of visual system222331$58
92134Imaging of retina4211,117$29
92136Measurement of corneal curvature and depth of eye126353$17

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine241,770$35,364
CyclosporineCyclosporine251,845$15,876
Bromfenac SodiumBromfenac Sodium601,579$7,319
LatanoprostLatanoprost32424,383$5,582
Prednisolone AcetatePrednisolone Acetate1234,860$5,048

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$301Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Golden Thaddeus Buckland, M.D.?

Tedicare shows public-source Medicare data for Golden Thaddeus Buckland, M.D. (NPI 1942402904), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Golden Thaddeus Buckland, M.D. have ACO affiliation data?

Golden Thaddeus Buckland, M.D. is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621).

What billing organization is linked to Golden Thaddeus Buckland, M.D.?

Golden Thaddeus Buckland, M.D. is linked to NORTH IDAHO EYE INSTITUTE P A (billing NPI 1699811646) in the available physician profile data.

Does Golden Thaddeus Buckland, M.D. have Open Payments data?

Golden Thaddeus Buckland, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.